While niclosamide has emerged as a CRC therapeutic due to its suppression of the Wnt pathway and Axin2/Snail-mediated EMT program [10,16,18], its effect on Hippo has not yet been determined. This evidence concerns the gene AXIN2 and colorectal carcinoma.